Corporate - Media & Press
ArrayIt® to exhibit in Palm Springs at the Laboratory Automation Conference.
Sunnyvale, CA, January 10, 2008 – On January 10th, Arrayit announced that the ArrayIt® Life Sciences Division would attend the Laboratory Automation Conference in Palm Springs. Lab Automation 2008 is being held at the Palm Springs Convention Center in Palm Springs California on January 27-29, 2008. The company will occupy booth 488 at the conference, and use its exhibit space to showcase a comprehensive suite of microarray products and services that includes nearly 500 life sciences products. ArrayIt® brand printing pins and printheads, microarrayers, scanners, content microarrays, substrate slides, microarray hardware and a host of other products will be on display for conference attendees. The SpotBot® 2 Personal Microarrayer, NanoPrint Enterprise Level Microarrayer, and the new SpotBot® Turbo Microarrayer will be among the instruments on display in Palm Springs. The Association of Laboratory Automation, the world’s only international organization devoted exclusively to laboratory automation, is sponsoring the Lab Automation 2008 Conference featuring ArrayIt and 150 other companies focused on various aspects of laboratory automation.
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.
Copyright 1993-2018 Arrayit Corporation. All rights reserved.